.On the heels of an FDA turndown for its chief rivalrous Novo Nordisk, Eli Lilly is gaining ground i...
.Simply a few months after dosing the first person in a period 2 test for freshly detected glioblast...
.Eli Lilly's hunt for excessive weight targets has actually led it to the dark genome. The Big Pharm...
.Toolbox Biosciences is proceeding up. The cell treatment business has added on $325 million in ammu...
.After elevating $170 thousand back in February, metabolic disease-focused BioAge Labs has filed to ...
.Aelis Farma's hopes of securing an easy, positive selection on a $one hundred thousand alternative ...
.ProKidney has stopped one of a pair of period 3 trials for its own cell therapy for kidney disease ...
.Vaxcyte unveiled what analysts named "spectacular" phase 1/2 records for its 31-valent pneumococcal...
.Recursion has stumbled through a very early exam of its own tech-enabled strategy to medicine disco...
.Contact it a situation of really good chemistry: Acepodia, a biotech based upon Nobel Prize-winning...